South Carolina-based ClearPoint Health has appointed Phil Giles as chief growth officer, starting 6 May, 2024.
The company develops and scales clinically integrated captives, including clinical providers in the sponsorship of medical stop loss captives.
In his role as chief growth officer, Giles is tasked with leading ClearPoint Health’s enterprise sales organisation.
Giles has joined ClearPoint from MSL Captive Solutions where he was managing director.
“Phil’s unparalleled expertise and strategic foresight in alternative risk and captive insurance are exactly what ClearPoint needs as we embark on this next phase of growth,” said Jeb Dunkelberger, CEO of ClearPoint Health.
“His profound alignment with our mission and vision promises to significantly propel our efforts to innovate within the alternative risk industry, ultimately benefiting a broad spectrum of employers with both standard and highly customized insurance solutions.”
In December, ClearPoint Health partnered with direct healthcare company, Nomi Health to help small and mid-sized employers across the US take better control of their health insurance costs.
In October, Dunkelberger told Captive Intelligence that there is no end in sight when it comes to current US health insurance challenges, with SMEs disproportionally being impacted.
“Joining ClearPoint Health marks a significant milestone in my career, deeply aligned with my passion for seeking out innovative and impactful opportunities within the sector,” Giles said.
“I am eagerly anticipating leading the growth initiatives at ClearPoint, contributing to the transformation of employer health insurance, and driving our collective mission forward.
“This opportunity to make a substantial difference, in alignment with ClearPoint’s forward-thinking ethos and commitment to excellence, is incredibly exciting.”